New HIV antibody cocktail enters human safety trials
NCT ID NCT07390955
First seen Feb 05, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This early-stage study tests whether lab-made antibodies that target HIV are safe and how the body processes them. About 83 healthy adults without HIV will receive the antibodies through an IV or under-the-skin shots, alone or combined. The goal is to check for side effects and measure antibody levels, not to cure HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alabama CRS (Site ID: 31788)
RECRUITINGBirmingham, Alabama, 35222, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Bridge HIV CRS (Site ID: 30305)
RECRUITINGSan Francisco, California, 94102, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Brigham and Women's Hospital Vaccine CRS (BWH VCRS) (Site ID: 30007)
NOT_YET_RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS (CITBM) - Unidad de Ensayos Clínicos (UNIDEC) (Site ID: 31970)
NOT_YET_RECRUITINGBellavista, Provincia Constitucional del Callao, 07006, Peru
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
George Washington University CRS (Site ID: 31608)
NOT_YET_RECRUITINGWashington D.C., District of Columbia, 20052, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Houston Advancing Research Team CRS (Site ID: 31473)
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Penn Prevention CRS (Site ID: 30310)
NOT_YET_RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seke South CRS (Site ID: 30294)
NOT_YET_RECRUITINGHarare, Zimbabwe
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Spilhaus CRS (Site ID: 30314)
NOT_YET_RECRUITINGHarare, Zimbabwe
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Ponce de Leon Center CRS (Site ID: 5802)
NOT_YET_RECRUITINGAtlanta, Georgia, 30308, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vanderbilt Vaccine (VV) CRS (Site ID: 30352)
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Via Libre CRS (Site ID: 31909)
NOT_YET_RECRUITINGLima Cercado, Lima region, 15001, Peru
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.